Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (17,239,777)	$ (11,404,934)
Adjustments to reconcile net loss to net cash used in operating activities
Compensation cost for stock options granted	7,102,118	1,053,496
Disposal of assets	5,806
Depreciation and amortization	52,789	44,197
Change in fair value of stock-based compensation liability	1,741,919	1,410,025
Changes in operating assets and liabilities:
Prepaid expenses	(352,511)	(258,889)
Research and development tax rebate receivable	(221,558)	(159,821)
Other assets	4,812	74,301
Accounts payable	(60,157)	18,427
Payroll liabilities	(35,650)	150,203
Accrued expenses	(99,186)	86,969
Other current liabilities	(27,047)	24,405
Net cash used in operating activities	(9,128,442)	(8,961,621)
CASH FLOWS FROM INVESTING ACTIVITY
Purchase of furniture and equipment	(7,625)	(110,906)
Net cash used in investing activities	(7,625)	(110,906)
CASH FLOWS FROM FINANCING ACTIVITY
Proceeds from issuance of Series B convertible preferred stock and warrants, net of issuance costs		12,290,551
Proceeds from exercise of warrants	11,336,710
Net cash provided by financing activities	11,336,710	12,290,551
NET INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH	2,200,643	3,218,024
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING BALANCE	10,490,493	7,272,469
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, ENDING BALANCE	12,691,136	10,490,493
SUPPLEMENTAL DISCLOSURES
Cash and cash equivalents	12,581,136	10,380,493
Restricted cash	110,000	110,000
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, ENDING BALANCE	12,691,136	10,490,493
NONCASH INVESTING AND FINANCING ACTIVITIES
Reclassification of stock-based liability awards to equity upon cancellation	3,151,944
Amortization of commitment shares		$ 72,790